HGF Office

The Hague

Benoordenhoutseweg 46,
2596 BC The Hague,
Netherlands

View on Google Maps

Contact the office

HGF is dedicated to providing a comprehensive service both across the Netherlands and internationally. Contact us to find out how we can work with your business.

Tel. +31 (0)70 240 0899

Email our team

HGF in the Hague opened in 2015 to cater for clients in the Benelux, providing direct representation at proceedings at the European Patent Office branch located in the Hague. Our attorneys can act directly before the EPO, the Dutch and the Belgian patent office, and file trade marks and designs at the Benelux Office for Intellectual Property.

Well-connected with the universities and small businesses in the area, our attorneys possess expertise in a range of fields including chemistry, life sciences, polymer sciences, bio sciences and pharmaceuticals. The team also collaborates with the firm’s multidisciplinary specialists across the company to offer IP services spanning trade marks, engineering and electronics.

Our team: The Hague

Search for a specialist

Use the options below to select one or more search areas

Latest updates

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article